MabVax Therapeutics (MBVX) Provides Update on SEC Investigation, Failure to Satisfy Continued Listing Rule
Tweet Send to a Friend
MabVax Therapeutics (NASDAQ: MBVX) disclosed in an SEC filing: Item 4.02Non-Reliance on Previously Issued Financial Statements or a Related Audit ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
